Connection

Solange Peters to Oncogene Proteins, Fusion

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Oncogene Proteins, Fusion.
Solange Peters
Connection Strength
0.360
Oncogene Proteins, Fusion
  1. Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor Therapy. Curr Treat Options Oncol. 2018 05 28; 19(7):37.
    View in: PubMed
    Score: 0.181
  2. EML4-ALK Variant Affects ALK Resistance Mutations. J Clin Oncol. 2018 04 20; 36(12):1257-1259.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.